Marshall recall is setback for new laryngeal mask:
This article was originally published in Clinica
Marshall Products is undertaking a full recall of its laryngeal airway devices (LADs), in response to reports of cuff failures during patient use. It is a setback for the Bath, UK company, as its LAD is a new product that was being supplied to the National Health Service for evaluation. The device failures were caused by leakages in some pilot balloon valves, according to a Medicines and Healthcare products Regulatory Agency (MHRA) alert issued yesterday (August 27 2003).
You may also be interested in...
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.